Amit Munshi was most recently President and CEO of Arena Pharmaceuticals Inc. (Nasdaq:ARNA). He assumed the helm in 2016 and led the $300m market cap company through a turnaround process including revamping the Board of Directors and management, resetting portfolio and operational priorities. ARNA raised approximately $900m in equity capital during this time, and an additional $800m from a partnership with United Therapeutics (Nasdaq:UTHR). In March 2022, Pfizer (NYSE: PFE) completed the acquisition of ARNA for approximately $6.7B. From 2011-2016, Mr. Munshi led turnarounds of TPG-backed EPIRUS Biopharmaceuticals, Inc., (acquired by private European pharma) and privately-held Percivia LLC (acquired by JNJ for undisclosed). Before Percivia, Mr. Munshi identified the lead asset (KYBELLA®), co-founded and was the Chief Business Officer of Kythera Biopharmaceuticals Inc. (Nasdaq:KYTH). At KYTHERA Mr. Munshi led several rounds of financing and completed a $370M ex-North America license transaction with a division of Bayer. KYTH was sold to Allergan (NYSE:AGN) for $2.1B. Prior to co-founding Kythera, Mr. Munshi spent 8 years at Amgen Inc. Mr. Munshi was the General Manager of Amgen’s European Nephrology Business Unit based in Switzerland. Prior to Switzerland, he was responsible for Amgen’s inflammation / immunology marketing including the launch of KINERET®, the acquisition of Immunex Corp (Nasdaq:IMNX) and the re-launch of Enbrel®. Previous to working at Amgen, Mr. Munshi held positions in sales, market research, marketing, managed markets, and business development during tenures at Astra Merck (Prilosec®) and IOLAB Corporation (a JNJ Company). Mr Munshi is also a co-founder of Oxeia Biopharmaceuticals, Inc (Private) and a member of the board of directors of Enterprise Therapeutics (Private), Galecto (Nasdaq;GLTO), StealthCo (MPM backed private company). He is an advisor to Ares Capital (Los Angeles) and Bank Pictet (Geneva/Zurich). Mr. Munshi received a MBA from The Peter Drucker Graduate School of Management at Claremont Graduate University and holds a BA in History and a BS in Quantitative Economics from the University of California, Riverside.